Document Detail


Small intestinal disaccharidase activity and ileal villus height are increased in piglets consuming formula containing recombinant human insulin-like growth factor-I.
MedLine Citation:
PMID:  9212041     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of orally administered IGF-I on intestinal development was assessed in piglets. Cesarean-derived, colostrum-deprived piglets received formula alone or formula containing 65 nM (500 microg/L) of recombinant human IGF-I. IGF-I intake averaged 200 microg/kg/d. On d 7 and 14 postpartum, piglets were killed, organs were removed and weighed, and tissue and blood samples were collected. The small intestine was divided into 13 segments that were weighed and measured. A sample of each segment was fixed in formalin, and the mucosa was scraped for enzyme analyses. Food intake, body and organ weights, intestinal weight, length, protein, DNA and RNA content did not differ between the treatment groups. Serum IGF-I, IGF-II, and IGF-binding protein profiles and tissue IGF-binding protein mRNA expression were also comparable between the treatment groups. In contrast, intestinal enzymes and villus height were increased by oral IGF-I. Lactase was approximately 2-fold higher (p < or = 0.05) in the jejunum and proximal ileum, and sucrase was approximately 50% higher (p < or = 0.05) in the jejunum of IGF-I-treated animals than in controls. Villus height in the terminal ileum was approximately 50% greater in IGF-I-treated animals than in controls (p = 0.03). In conclusion, orally administered IGF-I at 200 microg/kg did not affect whole body or organ growth or serum IGF-I concentrations; however, intestinal disaccharidase activity and ileal villus growth were responsive to orally administered IGF-I, supporting a potential role for milk-borne IGF-I in neonatal intestinal development.
Authors:
V M Houle; E A Schroeder; J Odle; S M Donovan
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Pediatric research     Volume:  42     ISSN:  0031-3998     ISO Abbreviation:  Pediatr. Res.     Publication Date:  1997 Jul 
Date Detail:
Created Date:  1997-09-09     Completed Date:  1997-09-09     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0100714     Medline TA:  Pediatr Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  78-86     Citation Subset:  IM    
Affiliation:
Department of Food Science and Human Nutrition, University of Illinois, Urbana 61801, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Animals, Newborn
Disaccharidases / metabolism*
Gene Expression
Humans
Ileum / drug effects*,  growth & development*,  metabolism
Insulin-Like Growth Factor Binding Proteins / blood,  genetics
Insulin-Like Growth Factor I / metabolism,  pharmacology*
Insulin-Like Growth Factor II / metabolism
Intestine, Small / drug effects*,  enzymology*,  metabolism
Liver / metabolism
RNA, Messenger / genetics,  metabolism
Recombinant Proteins / pharmacology
Swine
Grant Support
ID/Acronym/Agency:
R01 HD29264/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Insulin-Like Growth Factor Binding Proteins; 0/RNA, Messenger; 0/Recombinant Proteins; 67763-96-6/Insulin-Like Growth Factor I; 67763-97-7/Insulin-Like Growth Factor II; EC 3.2.1.-/Disaccharidases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Major circadian variations of glucose homeostasis in a patient with Rabson-Mendenhall syndrome and p...
Next Document:  L-thyroxine treatment of preterm newborns: clinical and endocrine effects.